2024
Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond
Sellinger J, Gilstad-Hayden K, Lazar C, Seal K, Purcell N, Burgess D, Martino S, Heapy A, Higgins D, Rosen M. Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond. Pain Medicine 2024, 25: s17-s27. PMID: 39514885, PMCID: PMC11548862, DOI: 10.1093/pm/pnae060.Peer-Reviewed Original ResearchConceptsPragmatic clinical trialsHealth careSocial supportChronic painEmotional healthHigher levels of painPain Management CollaboratoryEffective pain managementClinical trialsLevel of painEffectiveness of treatment outcomesPandemic impactAlcohol use disorder screeningCOVID-19-related impactsCOVID-19 pandemicChronic pain treatmentMental healthPain managementDisorder screeningNonpharmacological treatmentsPain treatmentStudy enrollmentCOVID-19HealthCare
2023
Military Sexual Trauma and its Association with Mental Health Among Sexual Minority and Heterosexual Veterans in the United States
Webermann A, Merians A, Gross G, Portnoy G, Rosen M, Pietrzak R. Military Sexual Trauma and its Association with Mental Health Among Sexual Minority and Heterosexual Veterans in the United States. LGBT Health 2023, 10: s61-s69. PMID: 37754922, DOI: 10.1089/lgbt.2023.0074.Peer-Reviewed Original ResearchConceptsMental health symptomsMilitary sexual traumaHealth symptomsHeterosexual veteransCurrent drug use disordersCurrent mental health symptomsCurrent posttraumatic stress disorderMultivariable logistic regressionDrug use disordersPrevalence of MSTMilitary characteristicsSexual traumaPosttraumatic stress disorderRepresentative web-based surveyHigh prevalenceUse disordersU.S. veteransWeb-based surveySociodemographic characteristicsSymptomsBivariate analysisLogistic regressionStress disorderMental healthPrevalence
2022
Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial
Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage G, Guerrero M, Corado K, Rosen M, Fletcher C, Daar E. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine 2022, 86: 104330. PMID: 36372731, PMCID: PMC9782816, DOI: 10.1016/j.ebiom.2022.104330.Peer-Reviewed Original ResearchConceptsHIV RNA viral loadRNA viral loadViral loadARV concentrationsUC groupIngestible sensorUsual care groupIngestible Sensor SystemOverall satisfaction rateInstitute of HealthGroup-based trajectory modelsAdvancing Translational SciencesAntiretroviral therapyHIV clinicCare groupText remindersIS groupImproved adherenceMeasure scoresSatisfaction rateStudy participantsAntiretroviralsMental healthAdherenceNational Institute